Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.
Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, Koerper MA, Abshire TC, DiMichele D, Hoots WK, Mathew P, Nugent DJ, Geraghty S, Evatt BL, Soucie JM. Kulkarni R, et al. Among authors: lusher jm. Haemophilia. 2017 Mar;23(2):207-214. doi: 10.1111/hae.13081. Epub 2016 Nov 4. Haemophilia. 2017. PMID: 27813214 Free PMC article.
Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council.
Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Kulkarni R, et al. Among authors: lusher jm. Haemophilia. 1999 Nov;5(6):410-5. doi: 10.1046/j.1365-2516.1999.00357.x. Haemophilia. 1999. PMID: 10583528
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.
Kulkarni R, Ponder KP, James AH, Soucie JM, Koerper M, Hoots WK, Lusher JM. Kulkarni R, et al. Among authors: lusher jm. Haemophilia. 2006 May;12(3):205-11. doi: 10.1111/j.1365-2516.2006.01277.x. Haemophilia. 2006. PMID: 16643202 Review.
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
Shapiro AD, Di Paola J, Cohen A, Pasi KJ, Heisel MA, Blanchette VS, Abshire TC, Hoots WK, Lusher JM, Negrier C, Rothschild C, Roth DA. Shapiro AD, et al. Among authors: lusher jm. Blood. 2005 Jan 15;105(2):518-25. doi: 10.1182/blood-2004-06-2283. Epub 2004 Sep 21. Blood. 2005. PMID: 15383463 Free article. Clinical Trial.
Perinatal management of newborns with haemophilia.
Kulkarni R, Lusher J. Kulkarni R, et al. Br J Haematol. 2001 Feb;112(2):264-74. doi: 10.1046/j.1365-2141.2001.02362.x. Br J Haematol. 2001. PMID: 11167818 Free article. Review. No abstract available.
Factor IX inhibitors and anaphylaxis in hemophilia B.
Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, DiMichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Katz J, Bergmann F, Ljung R, Petrini P, Lusher JM. Warrier I, et al. Among authors: lusher jm. J Pediatr Hematol Oncol. 1997 Jan-Feb;19(1):23-7. doi: 10.1097/00043426-199701000-00003. J Pediatr Hematol Oncol. 1997. PMID: 9065715
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.
Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, Laurian Y, Kasper CK, Mannucci PM. Lusher JM, et al. Haemophilia. 1998 Nov;4(6):790-8. doi: 10.1046/j.1365-2516.1998.00209.x. Haemophilia. 1998. PMID: 10028299 Clinical Trial.
188 results